Search for: "Foundation for Advancement of Innovative Medicine"
Results 61 - 80
of 207
Sort by Relevance
|
Sort by Date
20 Jul 2021, 7:08 pm
Thus, it is advisable for foreign patentees to prepare these formality documents in advance. [read post]
17 Jul 2021, 8:56 am
"B3W is actually the new form of two previous initiatives led by the American government, the United States Innovation and Competition Act (USICA) and the Blue Dot initiative. [read post]
13 Jul 2021, 10:58 am
Table of Contents INTRODUCTION.. 1 THE TRIPS AGREEMENT.. 2 THE ESSENTIAL MEDICINES DEBATE PRIOR TO THE COVID-19 PANDEMIC.. 4 III. [read post]
10 May 2021, 1:55 pm
Lee, director of the Wilson Center’s Hyundai Motor-Korea Foundation Center for Korean History and Public Policy. [read post]
6 May 2021, 3:02 am
Carey Foundation, and the amazing Board of Advisors and people behind FPI. [read post]
22 Apr 2021, 10:47 am
Couch Professor of Psychiatry and professor of radiology at the School of Medicine. [read post]
18 Mar 2021, 11:18 am
This would eliminate the obstacle to projects such as C-Tap in ways that align its purposes with the markets that made the innovation essential to its operation possible. [read post]
28 Feb 2021, 12:47 pm
Cooke (FJC Director), and Alan Tomkins and Reggie Sheehan, both of the National Science Foundation (NSF). [read post]
16 Nov 2020, 11:09 am
McCullough, the vice chief of internal medicine at Baylor University Medical Center; Dr. [read post]
9 Nov 2020, 11:50 am
Chan School of Public Health for health systems innovation, and of Lifebox, a nonprofit organization making surgery safer globally. [read post]
12 Oct 2020, 12:55 pm
Califf, head of Clinical Policy and Strategy for Verily and Google Health; Holly Fernandez, assistant professor of medical ethics and health policy at the University of Pennsylvania and Arturo Casadevall, professor of medicine at Johns Hopkins University. [read post]
3 Sep 2020, 4:00 am
Compared to other areas of social services such as medicine or education, we have comparatively little empirical data about justice issues, their social or financial impacts, or how to avoid or best deal with them. [read post]
10 Aug 2020, 2:17 pm
Panelists Nikolaj Gilbert, president and CEO at PATH; Kendall Hoyt, assistant professor of medicine at the Geisel School of Medicine at Dartmouth College; and Nicole Lurie, Strategic Advisor to the CEO at the Coalition for Epidemic Preparedness (CEPI), will join Margaret “Peggy” Hamburg, commissioner on the CSIS Commission on Strengthening America’s Health Security. [read post]
10 Aug 2020, 9:15 am
Elsewhere, the National Academies of Sciences, Engineering, and Medicine look at how federal R&D and commercialization funding programs for small businesses have been implemented by the National Science Foundation, and both the Urban Institute and the American Association for the Advancement of Science look at how data collection practices and technological platforms intersect with issues of racial equity. [read post]
24 Jul 2020, 7:07 pm
I’d also like to offer a special thanks to the Ford Presidential Foundation and Executive Director Joe Calvaruso. [read post]
7 Jul 2020, 10:10 pm
Taylor Distinguished Professor of Psychiatry at the School of Medicine, will receive the Chancellor’s Award for Innovation and Entrepreneurship. [read post]
4 Mar 2020, 7:11 am
At the same time, the European Medicine Agency (EMA) has activated its plan for managing emerging health threats.[5] The overall aim of the plan is to draw on the expertise of the European medicines network to provide fast-track scientific advice and give prompt feedback on any proposed medicine developments (which may follow, for example, from the IMI COVID-19 call). [1] Council Regulation No 73/2008 of 20 December 2007 setting up the Joint Undertaking for the… [read post]
2 Mar 2020, 11:04 am
Today (March 2, 2020) is the deadline for employers and other health benefit program sponsors, insurers, plan administrators and fiduciaries, health care providers, PBMs and other interested persons to comment on proposed federal rule change that would require insured health plans to count drug rebates and price concessions retained by pharmacy benefit managers (PBMs) as administrative expenses for purposes of determining if the issuing insurer is required to rebate premiums under the medical loss… [read post]
26 Feb 2020, 2:13 pm
“The Act reinvigorated research and development in America, spawning breakthrough discoveries ranging from high-yield crops to advanced medicines. [read post]
15 Jan 2020, 10:02 am
Many universities offer master’s programs in regulatory affairs that produce graduates who are unlicensed but highly qualified to manage the regulatory process for companies innovating and developing cutting edge products in science and medicine. [read post]
